*Up to a $300 savings for 3 bottles of RESTASIS MultiDose® or a 90-day supply of RESTASIS® single-use vials. Up to a $200 savings for 1 bottle of RESTASIS MultiDose® or a 30-day supply of RESTASIS® single-use vials. Patients whose prescriptions will be paid for in part or in whole by Medicare, Medicaid, or any similar federal or state healthcare program are not eligible for savings or rebates according to federal and state law.

The actual savings on your out-of-pocket costs for RESTASIS MultiDose® will vary according to refill quantity and personal healthcare insurance coverage. Please review the My Tears, My Rewards® Program guidelines to learn more.


 

Approved Use

RESTASIS® and RESTASIS MultiDose® Ophthalmic Emulsion help increase your eyes’ natural ability to produce tears, which may be reduced by inflammation due to Chronic Dry Eye. RESTASIS® and RESTASIS MultiDose® did not increase tear production in patients using anti-inflammatory eye drops or tear duct plugs.

Important Safety Information

Do not use RESTASIS® and RESTASIS MultiDose® Ophthalmic Emulsion if you are allergic to any of the ingredients. Be careful not to touch the container tip to your eye or other surfaces, to help avoid eye injury and contamination. RESTASIS® and RESTASIS MultiDose® should not be used while wearing contact lenses. If contact lenses are worn, they should be removed prior to use of RESTASIS® and RESTASIS MultiDose® and may be reinserted after 15 minutes.

The most common side effect is a temporary burning sensation. Other side effects include eye redness, discharge, watery eyes, eye pain, foreign body sensation, itching, stinging, and blurred vision.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Click here for full Product Information for RESTASIS® and RESTASIS MultiDose®.

View Desktop

Privacy Statement  |  Terms of Use  |  Contact Us  |
RES110169_v5 05/18   © 2018 Allergan, Inc. All rights reserved. This information is intended for residents of the United States. All trademarks are the property of their respective owners.

Approved Use

RESTASIS® and RESTASIS MultiDose® Ophthalmic Emulsion help increase your eyes’ natural ability to produce tears, which may be reduced by inflammation due to Chronic Dry Eye. RESTASIS® and RESTASIS MultiDose® did not increase tear production in patients using anti-inflammatory eye drops or tear duct plugs.

Important Safety Information

Do not use RESTASIS® and RESTASIS MultiDose® Ophthalmic Emulsion if you are allergic to any of the ingredients. Be careful not to touch the container tip to your eye or other surfaces, to help avoid eye injury and contamination. RESTASIS® and RESTASIS MultiDose® should not be used while wearing contact lenses. If contact lenses are worn, they should be removed prior to use of RESTASIS® and RESTASIS MultiDose® and may be reinserted after 15 minutes.

The most common side effect is a temporary burning sensation. Other side effects include eye redness, discharge, watery eyes, eye pain, foreign body sensation, itching, stinging, and blurred vision.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Click here for full Product Information for RESTASIS® and RESTASIS MultiDose®.

View Desktop

Privacy Statement  |  Terms of Use  |  Contact Us  |
RES110169_v5 05/18   © 2018 Allergan, Inc. All rights reserved. This information is intended for residents of the United States. All trademarks are the property of their respective owners.